We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guideline Advises Sponsors on Local Tolerance Testing for New Drugs
Guideline Advises Sponsors on Local Tolerance Testing for New Drugs
The European Medicines Agency is recommending that clinical trial sponsors evaluate local tolerance of medicinal products at contact sites on the body as part of a trial’s general toxicity studies.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor